- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04701671
Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids
December 2, 2025 updated by: Andrea Goldschmidt, University of Pittsburgh
Executive Functioning, Weight Trajectories, and Loss of Control Eating in Children With Overweight/Obesity: A Prospective Study
Overweight/obesity and loss of control eating (characterized by the sense that one cannot control what or how much one is eating) are prevalent among children and adolescents, and both are associated with serious medical and psychosocial health complications.
Although our recently published data suggest that youth with these conditions may have relative deficits in neurocognitive functioning, particularly working memory, understanding of how these processes and their neural correlates are related to change and stability in eating and weight-related outcomes over time is limited, thereby impeding development of targeted, optimally timed interventions.
The present study aims to assess prospective associations between general and food-specific executive functioning and underlying neural substrates, and eating and weight outcomes among children at varying levels of risk overweight/obesity and eating disorders, which will help guide research efforts towards the development of effective prevention and intervention strategies.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The current study will examine prospective associations among general and food-specific EF and related neural substrates, and the developmental course of weight gain and LOC eating from middle childhood through early adolescence. Specific aims are to:
- Investigate prospective associations between general and food-specific EF and z-BMI trajectories. We expect that across risk groups, a) poorer baseline performance on both general and food-specific behavioral EF measures will predict steeper z-BMI gain trajectories; and b) worsening general and food-specific EF will track with the steepest z-BMI gain trajectories.
- Investigate associations between general and food-specific EF and LOC eating trajectories. We expect that across risk groups, a) poorer baseline performance on general and food-specific behavioral EF measures will predict worsening course of LOC eating; and b) worsening general and food-specific EF will track with worsening course of LOC eating.
- Investigate prospective associations between EF neural substrates and trajectories of z-BMI and LOC eating. We expect that across risk groups, a) greater activation in prefrontal regions associated with EF (e.g., dorsolateral prefrontal cortex, dorsal cingulate, parietal cortex) during general and food-specific WM tasks, and b) smaller decreases in activation of these regions over 18 months, will predict steeper z-BMI gain trajectories and worsening course of LOC eating.
Study Type
Observational
Enrollment (Estimated)
180
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Erin Stalvey, B.S.
- Phone Number: 412-586-9066
- Email: stalveyer@upmc.edu
Study Contact Backup
- Name: Chloe Hudson, B.S.
- Phone Number: 412-586-9082
- Email: bitelab@upmc.edu
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Recruiting
- University of Pittsburgh
-
Contact:
- Erin Stalvey, B.S.
- Phone Number: 412-586-9066
- Email: stalveyer@upmc.edu
-
Principal Investigator:
- Andrea B Goldschmidt, Ph.D.
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Active, not recruiting
- Weight Control & Diabetes Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 12 years (Child)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Participants will include 180 children (9-12y) representing a spectrum of risk for eating and weight disorders, including overweight/obese (BMI ≥ 85th age- and sex-adjusted percentile) with LOC eating (n=60), overweight/obese without LOC eating (n=60), and healthy weight without LOC eating (5th percentile ≤ BMI < 85th percentile; n=60).
Description
Inclusion Criteria:
- Not currently taking any medications known to affect weight or appetite
- Free of any current or past medical or psychiatric conditions known to significantly affect eating or weight (e.g., diabetes, bulimia nervosa), with the exception of binge eating disorder
- In the low average range or higher on measures of general intellectual functioning
- Free of any conditions affecting executive functioning (e.g., recent concussion, history of traumatic brain injury)
- Fluent in English, and able to read and comprehend study materials
- Not currently pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Normal Weight Control, no MRI-scan (30 participants)
Adolescents with a BMI percentile under 85% who are not randomly assigned to undergo MRI scans at baseline and 18-months.
|
Observational data will be obtained through self-report measures, parental report measures, cognitive assessments, and a semi-structured interview.
|
|
Normal Weight Control with MRI-scan (30 participants)
Adolescents with a BMI percentile under 85% who are randomly assigned to undergo MRI scans at baseline and 18-months.
|
Observational data will be obtained through self-report measures, parental report measures, cognitive assessments, fMRI imaging, and a semi-structured interview.
|
|
Overweight Control, no MRI-scan (30 participants)
Adolescents with a BMI percentile at 85% or higher who are not randomly assigned to undergo MRI scans at baseline and 18-months.
|
Observational data will be obtained through self-report measures, parental report measures, cognitive assessments, and a semi-structured interview.
|
|
Overweight Control with MRI-scan (30 participants)
Adolescents with a BMI percentile at 85% or higher who are randomly assigned to undergo MRI scans at baseline and 18-months.
|
Observational data will be obtained through self-report measures, parental report measures, cognitive assessments, fMRI imaging, and a semi-structured interview.
|
|
Overweight/Obese Experimental, no MRI-scan (30 participants)
Adolescents with a BMI percentile at 85% or higher, who report loss of control eating episodes and are not randomly assigned to undergo MRI scans at baseline and 18-months.
|
Observational data will be obtained through self-report measures, parental report measures, cognitive assessments, and a semi-structured interview.
|
|
Overweight/Obese Experimental with MRI-scan (30 participants)
Adolescents with a BMI percentile at 85% or higher, who report loss of control eating episodes and are randomly assigned to undergo MRI scans at baseline and 18-months.
|
Observational data will be obtained through self-report measures, parental report measures, cognitive assessments, fMRI imaging, and a semi-structured interview.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI (Body Mass Index)
Time Frame: Change in BMI from baseline to 24 months
|
BMI will be assessed using height and weight (cm/g)
|
Change in BMI from baseline to 24 months
|
|
Eating Behavior
Time Frame: Change in eating behavior from baseline to 24 months
|
Eating behavior will be assessed using the Eating Disorder Examination (EDE), a semi-structured interview.
Global scores are calculated, with higher scores indicating higher disordered eating symptomology.
|
Change in eating behavior from baseline to 24 months
|
|
General Executive Functioning
Time Frame: Change in general executive functioning from baseline to 24 months
|
A general n-back task that will involve continuous presentation of neutral stimuli (letters or numbers).
Participants indicate via button press whether the target (current) stimulus was presented n items ago.
|
Change in general executive functioning from baseline to 24 months
|
|
Food-Specific Executive Functioning
Time Frame: Change in food-specific executive functioning from baseline to 24 months
|
A food-specific WM task that involves continuous presentation of stimuli representing food and non-food items.
Participants indicate via button press whether the target (current) stimulus was presented n items ago.
|
Change in food-specific executive functioning from baseline to 24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Andrea B. Goldschmidt, Ph.D., University of Pittsburgh
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 10, 2020
Primary Completion (Estimated)
May 9, 2028
Study Completion (Estimated)
May 9, 2028
Study Registration Dates
First Submitted
January 6, 2021
First Submitted That Met QC Criteria
January 6, 2021
First Posted (Actual)
January 8, 2021
Study Record Updates
Last Update Posted (Actual)
December 10, 2025
Last Update Submitted That Met QC Criteria
December 2, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY21070033
- R01DK120597 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Obesity
-
University of British ColumbiaThe Hospital for Sick Children; Canadian Institutes of Health Research (CIHR); Alberta Health services and other collaboratorsCompleted
-
Hasselt UniversityJessa HospitalCompletedObesity, Pediatric
-
Azienda Ospedaliera Universitaria Integrata VeronaNot yet recruitingObesity, Pediatric
-
University of British ColumbiaHeart and Stroke Foundation of Canada; Public Health Agency of Canada (PHAC); Childhood Obesity Foundation and other collaboratorsCompleted
-
Columbia UniversityCompletedVitamin D Deficiency | Obesity, Morbid | Obesity, Childhood | Obesity, PediatricUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
University Hospital, Clermont-FerrandAME2P Laboratory, Clermont Auvergne UniversityCompleted
-
Medical College of WisconsinWisconsin Department of Health and Family Services; Children's Health System...TerminatedPediatric Obesity | Pediatric OverweightUnited States
-
Virginia Commonwealth UniversityCompletedObesity, PediatricUnited States
-
Kahramanmaras Sutcu Imam UniversityCompletedPediatric Obesity | Pediatric DentistryTurkey
Clinical Trials on Observational (not including MRI scanning)
-
Wake Forest University Health SciencesCompleted
-
Brighton and Sussex University Hospitals NHS TrustCompletedLacrimal Duct Obstruction | Lacrimal StenosisUnited Kingdom
-
Assistance Publique Hopitaux De MarseilleCompleted
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasCompletedMalignant Gliomas | Astrocytomas | OligodendrogliomasUnited States
-
Laval UniversityNot yet recruitingMechanical Ventilation | Hemodynamic Changes | Respiratory Acidosis in ICU Patients | Right Ventricular (RV) DysfunctionCanada
-
Chinese PLA General HospitalNot yet recruitingAge-related Hearing Loss
-
Chinese PLA General HospitalPeking University People's Hospital; Xuanwu Hospital, Beijing; Beijing Youyi...Not yet recruitingDementia | Age-related Hearing LossChina
-
Zhejiang Chinese Medical UniversityNot yet recruitingPain | Diabetic Peripheral Neuropathy (DPN)China
-
University of SheffieldSheffield Teaching Hospitals NHS Foundation Trust; Liverpool John Moores University and other collaboratorsNot yet recruiting
-
Hospices Civils de LyonNot yet recruiting